[Eicosanoids in bronchial asthma].
Makino
S
S
Department of Medicine and Clinical Immunology, Dokkyo University, School of Medicine.
D000179:Acrylates / Q000627:therapeutic use*; D001095:Arachidonic Acids / Q000096:biosynthesis* / Q000276:immunology / Q000502:physiology; D001249:Asthma / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism*; D016227:Benzoquinones; D001992:Bronchoalveolar Lavage Fluid; D002867:Chromones / Q000494:pharmacology / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology / Q000627:therapeutic use*; D007962:Leukocytes / Q000378:metabolism; D016859:Lipoxygenase Inhibitors; D008168:Lung / Q000378:metabolism; D008264:Macrophages / Q000378:metabolism; D008689:Methacrylates / Q000494:pharmacology / Q000627:therapeutic use*; D011809:Quinones / Q000494:pharmacology / Q000627:therapeutic use; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors
D000179:Acrylates; D001095:Arachidonic Acids; D016227:Benzoquinones; D002867:Chromones; D016861:Cyclooxygenase Inhibitors; D016859:Lipoxygenase Inhibitors; D008689:Methacrylates; D011809:Quinones; C036837:2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone; D013930:Thromboxane-A Synthase; C034364:ozagrel; C047681:pranlukast; D007213:Indomethacin